Cargando…

Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progression

BACKGROUND: We annually monitored stable compensated cirrhosis (CC) patients to evaluate serial variation in blood serum, liver stiffness, and multiparametric magnetic resonance imaging (mpMRI) measures to provide reference change values (RCV) and sample size measures for future studies. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, Christopher R., Cox, Eleanor F., Palaniyappan, Naaventhan, Aithal, Guruprasad P., Francis, Susan T., Guha, Indra Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588852/ https://www.ncbi.nlm.nih.gov/pubmed/36274113 http://dx.doi.org/10.1186/s41747-022-00303-y

Ejemplares similares

MRI assessment of altered dynamic changes in liver haemodynamics following a meal challenge in compensated cirrhosis
por: Cox, Eleanor F., et al.
Publicado: (2018)

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
por: Palaniyappan, Naaventhan, et al.
Publicado: (2016)

Guidelines on the management of ascites in cirrhosis
por: Aithal, Guruprasad P, et al.
Publicado: (2021)

The Utility of Scoring Systems in Predicting Early and Late Mortality in Alcoholic Hepatitis: Whose Score Is It Anyway?
por: Palaniyappan, Naaventhan, et al.
Publicado: (2012)

Diagnostic accuracy of serum ascites albumin gradient (SAAG) in a contemporary unselected medical cohort
por: Subhani, Mohsan, et al.
Publicado: (2022)

Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients
por: Bradley, C., et al.
Publicado: (2018)

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
por: Harman, David J, et al.
Publicado: (2015)

Noninvasive markers for esophageal varices in children with cirrhosis
por: Rahmani, Parisa, et al.
Publicado: (2020)

Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
por: Knight, Holly, et al.
Publicado: (2020)

New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices
por: Ljubičić, Neven, et al.
Publicado: (2012)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Biomarkers in Liver Disease: Emerging Methods and Potential Applications
por: Aithal, Guruprasad P., et al.
Publicado: (2012)

Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fraction
por: Bawden, Stephen James, et al.
Publicado: (2022)

Noninvasive diagnosis of compensated cirrhosis using an analysis of the time–intensity curve portal vein slope gradient on contrast-enhanced ultrasonography
por: Goto, Yuichi, et al.
Publicado: (2013)

Clusters of psychosis: compensation as a contributor to the heterogeneity of schizophrenia
por: Palaniyappan, Lena
Publicado: (2023)

Transient Elastography in Community Alcohol Services: Can It Detect Significant Liver Disease and Impact Drinking Behaviour?
por: Subhani, Mohsan, et al.
Publicado: (2022)

Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2016)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Economic evaluation of covered stents for transjugular intrahepatic portosystemic stent shunt in patients with variceal bleeding and refractory ascites secondary to cirrhosis
por: Mattock, Richard, et al.
Publicado: (2021)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
por: Tanajewski, Lukasz, et al.
Publicado: (2017)

Small Bowel Abnormalities in Patients with Compensated Liver Cirrhosis
por: Aoyama, Taiki, et al.
Publicado: (2012)

Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2018)

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis
por: Bloom, P.P., et al.
Publicado: (2022)

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis
por: Llovet, Laura‐Patricia, et al.
Publicado: (2022)

Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia
por: Abdo, Ayman A., et al.
Publicado: (2007)

Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2016)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Compensated liver cirrhosis: Natural course and disease-modifying strategies
por: Kumar, Ramesh, et al.
Publicado: (2023)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
por: Buscail, Camille, et al.
Publicado: (2018)

Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis
por: Balakrishnan, Maya, et al.
Publicado: (2021)

Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
por: Thanapirom, Kessarin, et al.
Publicado: (2021)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis
por: Reiberger, Thomas
Publicado: (2021)

Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
por: McGill, Mitchell R., et al.
Publicado: (2021)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis
por: Bangaru, Saroja, et al.
Publicado: (2020)

Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis
por: Innes, Hamish, et al.
Publicado: (2022)

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease
por: Parkes, Julie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lmh0klj80rbg6n5fk5j4ojhjlb